Fehr F, Lo LA, Nelson C, Nanson K, Diehl L, Nielson K, Reddon H, Walsh Z Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: obstacles and opportunities for improvement Int J Ment Health Nurs PubMed

Reddon H, Socías ME, DeBeck K, Hayashi K, Walsh Z, Milloy MJ Cannabis use to manage stimulant cravings among people who use unregulated drugs Addict Behav PubMed

Reddon H, Lake S, Socías ME, Hayashi K, DeBeck K, Walsh Z, Milloy MJ Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis Int J Drug Policy PubMed

Lake S, Kerr T, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ The cannabis-dependent relationship between methadone treatment dose and illicit opioid use in a community-based cohort of people who use drugs Cannabis Cannabinoid Res PubMed

Lake S, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ Methadone dose, cannabis use, and treatment retention: findings from a community-based sample of people who use unregulated drugs J Addict Med PubMed

Argento E, Christie D, Mackay L, Callon C, Walsh Z Psychedelic-assisted psychotherapy after COVID-19: the therapeutic uses of psilocybin and MDMA for pandemic-related mental health problems Front Psychiatry PubMed

Lake S, Nosova E, Buxton J, Walsh Z, Socías ME, Hayashi K, Kerr T, Milloy MJ Characterizing motivations for cannabis use in a cohort of people who use illicit drugs: a latent class analysis PLoS One PubMed

Lake S, Kerr T, Buxton J, Walsh Z, Marshall BDL, Wood E, Milloy MJ Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians J Psychopharmacol PubMed

Lake S, Walsh Z, Kerr T, Cooper ZD, Buxton J, Wood E, Ware MA, Milloy MJ Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: a longitudinal analysis PLoS Med PubMed